ABIONYX Pharma SA's total assets for Q2 2026 were €36.54M, an increase of 184.03% from the previous quarter. DE:609 total liabilities were €20.86M for the fiscal quarter, a 142.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.